Hepatocellular carcinoma(HCC)is among the leading causes of cancer-related mortality.The principal treatment is surgical resection or liver transplantation,depending on whether the patient is a suitable transplant can...Hepatocellular carcinoma(HCC)is among the leading causes of cancer-related mortality.The principal treatment is surgical resection or liver transplantation,depending on whether the patient is a suitable transplant candidate.However,in most patients with HCC the diagnosis is often late,thereby excluding the patients from definitive surgical resection.Medical treatment includes sorafenib,which is the most commonly used systemic therapy;although,it has been shown to only minimally impact patient survival by several months.Chemotherapy and radiotherapy are generally ineffective.Due to the poor prognosis of patients with HCC,newer treatments are needed with several being in development,either in preclinical or clinical studies.In this review article,we provide an update on the current and future medical and surgical management of HCC.展开更多
文摘Hepatocellular carcinoma(HCC)is among the leading causes of cancer-related mortality.The principal treatment is surgical resection or liver transplantation,depending on whether the patient is a suitable transplant candidate.However,in most patients with HCC the diagnosis is often late,thereby excluding the patients from definitive surgical resection.Medical treatment includes sorafenib,which is the most commonly used systemic therapy;although,it has been shown to only minimally impact patient survival by several months.Chemotherapy and radiotherapy are generally ineffective.Due to the poor prognosis of patients with HCC,newer treatments are needed with several being in development,either in preclinical or clinical studies.In this review article,we provide an update on the current and future medical and surgical management of HCC.
